Details for New Drug Application (NDA): 021015
✉ Email this page to a colleague
The generic ingredient in ANDROGEL is testosterone. There are sixty-nine drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 021015
Tradename: | ANDROGEL |
Applicant: | Besins Hlthcare |
Ingredient: | testosterone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 021015
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | GEL;TRANSDERMAL | Strength | 25MG/2.5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Feb 28, 2000 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | GEL;TRANSDERMAL | Strength | 50MG/5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Feb 28, 2000 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | GEL, METERED;TRANSDERMAL | Strength | 12.5MG/1.25GM ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Sep 26, 2003 | TE: | RLD: | Yes |
Expired US Patents for NDA 021015
Complete Access Available with Subscription